Kiener Peter A 4
4 · Cue Biopharma, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Kiener Peter A
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-03+10,000→ 10,000 totalExercise: $2.66Exp: 2033-01-02→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on January 3, 2023. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date.